Can the Electrophysiological Action of Rosiglitazone Explain its Cardiac Side Effects?

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 3720-3728
Author(s): A. Szebeni, N. Szentandrassy, P. Pacher, J. Simko, P. P. Nanasi, V. Kecskemeti

Ligand-Based Pharmacophore Detection and Screening of Potential Glitazones

Journal: Current Enzyme Inhibition
Volume: 8 Issue: 1 Year: 2012 Page: 22-46
Author(s): Ritesh Agrawal, Pratima Jain, Subodh N. Dikshit

PPARγ Agonists: Beneficial Effect on Blood Pressure Beyond Glycemic Control?

Journal: Current Hypertension Reviews
Volume: 2 Issue: 1 Year: 2006 Page: 47-60
Author(s): Panteleimon A. Sarafidis, Anastasios N. Lasaridis

A Review on the Development in the Field of NIDDM based Thiazolidinedione PPARγ Agonists

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13 Issue: 5 Year: 2013 Page: 706-712
Author(s): Pooja S. Banerjee, Subir Samanta

Balaglitazone: A Second Generation Peroxisome Proliferator-Activated Receptor (PPAR) Gamma (γ) Agonist

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2012 Page: 87-97
Author(s): R. Agrawal, P. Jain, S. N. Dikshit

Synthetic Thiazolidinediones: Potential Antidiabetic Compounds

Journal: Current Organic Chemistry
Volume: 15 Issue: 1 Year: 2011 Page: 108-127
Author(s): Aurelio Ortiz, Estibaliz Sansinenea

Classification of Therapeutic and Experimental Drugs for Brown Adipose Tissue Activation: Potential Treatment Strategies for Diabetes and Obesity

Journal: Current Diabetes Reviews
Volume: 12 Issue: 4 Year: 2016 Page: 414-428
Author(s): Jogeshwar Mukherjee,Aparna Baranwal,Kimberly N. Schade

Clinical Thiazolidinediones as PPARγ Ligands with the Potential for the Prevention of Cardiovascular Disease in Diabetes

Journal: Current Diabetes Reviews
Volume: 2 Issue: 2 Year: 2006 Page: 227-239
Author(s): Stephanie T. de Dios, Richard C. OBrien, Peter J. Little

Journal: Current Vascular Pharmacology
Volume: 11 Issue: 3 Year: 2013 Page: 293-298
Author(s): Evelyn Torsney, Grisha Pirianov, Gillian W. Cockerill

The First Approved Agent in the Glitazar’s Class: Saroglitazar

Journal: Current Drug Targets
Volume: 15 Issue: 2 Year: 2014 Page: 151-155
Author(s): Ritesh Agrawal